EVENTS:   The Roaring 2020s or a Rerun of the 1970s? - Edward Yardeni/Yardeni Research - 24 Mar 26   Best Equity Short Ideas Conference Call 13 - Thomas Chanos/Badger Consultants & Dr. Aaron Fletcher/Bios Research & Jonathan Telgener/Channel Dynamics & Ed Steele/Iron Blue Financials & John Zolidis/Quo Vadis Capital & Mark Hiley/The Analyst - 26 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Filters

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

FTSE 100 stocks & sector review

Messels

Messels currently has 19 long positions in their FTSE 100 Momentum portfolio having closed their position in Rio Tinto after it pulled back in the five-year range and broke medium term relative support. They remain overweight Retail and in particular, Howden, Tesco and Marks & Spencer which maintain uptrends and JD Sports and Kingfisher which renew base formations. Other stocks highlighted in their technical review this week include Informa, which has rallied back to the highs and rallies from relative uptrend support; while M&G finds 18-month uptrend support and develops a base at the bottom of the relative range.

Edition: 191

- 26 July, 2024


FTSE 100 Momentum Portfolio

Messels

Messels position themselves as a dedicated technical research team who work for fund managers at a fraction of the cost of a typical sell-side analyst. Highlights from their weekly report: 1) Informa - new Buy as it rallies from support at the bottom of the 12m range and gains relative momentum. 2) Rio Tinto - develops bases at medium term support. 3) Croda - finding 7-year price and relative uptrend support. 4) Imperial Brands - renews uptrends from support above 2-year price and relative bases. 5) GSK - reaching support at the bottom of the 10-year range.

Edition: 146

- 14 October, 2022